Angela Hwang is a member of Pfizer’s Executive Team and Group President of the Pfizer Biopharmaceuticals Group, which is the commercial organization of Pfizer. Her organization of 26,000 colleagues across 125 countries is responsible for bringing over 600 innovative medicines and products to patients. In 2020, more than 420 million people benefited from a Pfizer Biopharma medicine or vaccine to improve their health and, in some cases, save their lives. Altogether, Pfizer Biopharma generated almost $42 billion in 2020 revenues.
As Group President of Pfizer Biopharma, Angela leads 7 commercial business units. Together, these businesses strive to deliver transformational medicines that address major global health priorities in cancer, rare disease, inflammation & immunology, primary care, infectious diseases, and preventative care with vaccines.
Angela has been with Pfizer for over 24 years, working across all geographies and therapeutic areas. She is motivated by the common purpose that all Pfizer colleagues share, to bring breakthroughs to patients, regardless of where they are in the world. Her childhood as an Asian girl growing up in apartheid South Africa, defined her worldview and underscored the importance of equity in everything she does today.